Ode to California Pacific Medical Center Hepatology Center

Today was my bi-weekly blood test. It was a quick and dirty one-tube wonder that measured the standard blood chemistry, hemogloblin, neutrophils, white and red cell counts, etc. It was a screening day for folks who were applying to be in one of the upcoming drug trials, so there was a bit of a wait at the Hepatology Center lab. They have a TV in the waiting room playing nature DVDs on a continuous loop with the sound turned way down. Anyone who has read much of this blog knows how much I like watching concentration free video, so it was not a burden to sit in a comfortable chair and wait my turn.

While waiting my managing nurse from the Roche drug trial (RO5024048 or RG7128 depending on which company you favor) AVB saw me and stopped by to chat me up. Actually she just sat down to ask how I was doing but we older guys can always dream. We talked for a bit and she asked if I was still on treatment, how much longer it was to last, if I was negative, whether I was still working and how I was coping in general. (I asked about her mother and she told me that she was fine, but probably needed to have somebody to talk to outside her family).

I gave her the lowdown on how I was doing – still on treatment, 54 weeks in 24 to go, I have been negative for 12 weeks now, I am still working 4 days a week and aside from feeling very tired all the time and stupid some of the time I felt I was doing okay. Like many people with experience in either undergoing or administering Hepatitis C treatment, she was surprised I am still working. She urged me to make sure that working was not taking too much out of me. She emphasized that if work wore me out too much, it could inhibit my ability to succeed at treatment and that I have to remember to think of my own health first. She reiterated something that she told me several times when I was in the experimental trial, that they would write the papers for a disability claim for me whenever I felt it was necessary. We talked briefly about our holiday plans; she patted my knee (see what I meant about chatting me up…) and went about her business.

I mention that meeting because it is characteristic of the vast majority of interactions I have had with the staff of the CPMC Hepatology Center. From the folks at the front desk to the people who draw blood, to the nurses, technicians and the doctors themselves, they all exhibit genuine concern and care for their patients. I am a relatively relaxed patient in most circumstances, but I have seen them show tremendous patience with difficult, disturbed, confused and unresponsive patients. They are gentle with the physically challenged, explain in great detail the nature of diseases and care, are helpful with the people for whom English is not a first language and generally kind and concerned with those under their treatment.

When they are dealing with me personally, I never feel that they are rushing me through our appointments. They answer my questions (and in fact are more than willing to grill me about how I am reacting and whether previously reported symptoms are still present) and explain medications and procedures until they are sure I understand what is going on. My nurse Alex (who, sadly, is leaving for a better paying job with another health organization) goes so far as to leave messages on all my various phones and then insists I call him back to make sure that his information has gotten to me. Dr. Bzowej has first-rate knowledge of the field and has a warm manner that is a great comfort during a trying time.

There are folks I know (a few in the local Hep C support group) who have not had experiences as positive as mine at CPMC. My wife claims that some of my experience is because I am a good person and that difficult people tend to have difficult experiences but she is not exactly unbiased in her analysis. Nonetheless, I have to say that the CPMC Hepatology Center and the people who staff it have been great to me and a huge reservoir of support for the past year. Let’s hope they only have to play that role for me until next May and that they never have to treat me again after that.

Another Day Another Insurance Functionary

It is amazing how exhausting phone conversations with health insurance bureaucrats can be. After composing and sending several emails, I hit the phones to try for more direct answers concerning the details of the potential coverages available to me. I talked to a number of folks who ran the gamut from clueless, bewildered, helpful but clueless, helpful but wrong and helpful and possibly correct. The problem is that determining the difference between the final two types, helpful but wrong and helpful but possible correct is neither easy nor readily apparent.

After sending a set of detailed questions to my HR department, they punted me further on to the insurance broker who handles our account. They were nice folks and quite helpful, but the insurance plan drug formulary comparison tool on their website indicated that Neupogen and Ribavirin were not in either the Blue Cross or the Healthnet formularies. I found that a bit hard to believe as both are large health care providers and must have more than a few Hep C patients. I managed to track down the pdf file of the actual Blue Cross formulary updated as of November, 2010 and all the drugs I am taking are in their formulary. Naturally, this does not raise one’s confidence level about the quality of the answers to the other questions I asked.

The two other questions I asked were about the drug copays for specialty drugs and any special tasks I needed to complete to insure continuity of care. The drug co-payment information they provided was straight out of the handbook and concerned the difference in co-payments between generic and brand name drugs, it did not address the specialty drug question. It may not even be an issue, but, again, it’s all up in the air until the actual paperwork goes through.

As far as continuity of care: heck, not a problem. Just let everyone know as soon as possible that the change in plans is occurring, get them to write new prescriptions for everything you take, get authorizations from the insurance company for all of them and have it all happen before any of the current scrips run out. Oh, and have it all happen during the highly productive holiday season.

If only they could switch the open enrollment period to some other time of the year...Ho! Ho! Ho!

The Joy of American Health Insurance

Two days ago the employees in my organization entered our annual health insurance open-enrollment season. While this has always been a pain in the butt process, it assumes greater importance given my current situation. Considering that I have 22 weeks left to complete my course of Hepatits C treatment, continuity of care becomes an issue of primary importance.

I currently have Blue Shield insurance. I enrolled in Blue Shield when my organization’s health care broker dropped my previous insurance company. This year, they have dropped Blue Shield from their list of available plans. They have substituted Anthem Blue Cross, one of the more notorious insurance companies in the country and Healthnet, one of the most expensive. Just the sort of additional stress one looks forward to at this most wonderful time of the year.

I am currently enrolled in an HMO under the Blue Shield umbrella. This is not an HMO in the traditional sense of Kaiser Permanente or Group Health; that is a company that owns it’s own medical facilities. Instead Blue Shield contracts with physician groups and hospitals that provide the same services as a HMO. My physician group is associated with both Blue Shield, Healthnet and Blue Cross, so I should – emphasis should – be able to transfer my care over to one of the other umbrella payment plans without a great deal of difficulty. Even if that is the case, however, there is no guarantee of consistency in the drugs each organization has in their drug formularies and particularly in the amount of co-payment they charge for the more exotic drugs necessary for treatment: Pegasys (interferon), Neupogen, Procrit and Ribavirin. Currently my co-payments for these bad boys run about $315.00 per month. Will the number go up, down, sideways? Inquiring minds want to know.

I have begun my research, of course. I have a series of questions in to my HR department, such as it is; I have called my specialty pharmacy to initiate inquiries as to their knowledge of co-payment differences; I have talked to my doctors about the necessary paperwork I will have to produce to ensure that I will have uninterrupted care. Oh yes, I have ten days to make my decision.

Would that our country was a sane one and health care was viewed as both a necessity and something citizens could expect from the taxes they pay. Thank heaven I at least have an employer that provides health insurance plans or I might be living in a box right now – the actual retail cost billed to the insurance company for the drugs I take on a monthly basis is just over $7,000, quite a bit more that I make in pay.

Soon enough information will come pouring in and decisions will be made, I can hardly wait for the conversations with insurance functionaries, Joy To The World, eh?

Avoid Being a Ralph Star on the Job

Rules for managing nausea at work:

1. Recognize when those waves of nausea you occasionally feel become more insistent.
2. Make sure the rest room is available and not in use.
3. Move quickly to the rest room when needed.
4. Make sure the rest room has a solid, thick door and is not one of those hollow pocket doors or, even worse, a jalousie style door.
5. Attempt to void your digestive tract in as quiet a manner as possible.
6. Clean all affected areas thoroughly.
7. Attempt to return to your work area discreetly.


I think I managed to follow rules 2, 3 and 6 pretty well; the others not so much. It was last Friday afternoon and I suspect that it all happened the way it did because it had not happened before. I have been remarkably free of the truly vicious nausea that afflicts many people on Hep C treatment. I get waves of it from time to time, but usually by drinking some water, getting up and walking around and doing some controlled breathing, I have been able to manage it. On Friday, things were different.

In mid-afternoon I began to have some waves of nausea. I used my usual tactics to try to manage them, but they didn’t really go away. I felt them get stronger and realized that this might require a trip to the toilet. Then I began to cough (as you sometimes do during these delightful events) and realized it was game on. I ran to the bathroom. As an aside, I work on a mezzanine with a small bathroom close by. Unfortunately because of the design, the bathroom has a hollow pocket door that slides closed. As I ran into the room, I slid the door closed (or as it turned out, almost closed). I then began to noisily lose my stomach contents. It was over quickly enough and after pulling myself together and cleaning up a bit, I walked out of the bathroom. To see my boss standing there with a concerned look on his face as he asked me if I were going to live.

It turns out that because of the flimsy nature of the door and the fact that it did not close completely as I rushed in, it was quite clear throughout the building that someone was having digestive problems. Luckily it was late enough in the afternoon that there were only my boss, one coworker and one volunteer left in the building. If it had all happened about a half-hour earlier, I might have had a crowd of concerned volunteers waiting for me outside the bathroom wondering if my internal organs were still internal.

It’s not exactly that it is embarrassing to have this happen, it’s more that I like to be somewhat discreet and not subject everyone in the building to my health issues. I don’t hide the fact that I have Hep C, but I don’t advertise either the fact that I have it or the fact that I am undergoing treatment. It is just something that doesn’t need to be rubbed in everyone’s face. No doubt an artifact of my Minnesota upbringing.

But it did lead me to formulate the 7 simple rules for avoiding becoming a center of attention at work. So take it for what it’s worth. To be a star or not to be a star, aye, there’s the rub.

Deciding About Treatment - did I avoid a disaster?

I few posts ago I wrote a bit about Questions you need to think about in regards to treatment.

Let me tell you about the first time I made a decision

It was my second visit to the Gastroenterologist, the fabulous Doctor C. The first visit was relatively brief in that we went over a bit about the disease and he order a full set of labs to determine the genotype of the virus, the viral load and a bunch of liver function tests as well as some general blood work. The primary result of the visit was to realize that I had a great doctor on my side. Doctor C is a warm, supportive personality and also a doctor who Listens. He is not one of those folks who are merely waiting for a chance to talk when he is silent. He listens carefully, gives considered answers and is well versed in the details of the disease. He is not a certified Hepatologist, but he does a great deal of work with coinfected HIV patients and is up on the research and the treatments for Hep C.

The second visit was more detailed as we went over the results of the labs. The bad news was that I had genotype 1 which is the hardest to cure. It is also the one infecting the vast majority of North Americans. My viral load was over 4,000,000 IU per ml. which put me in the category considered to be medium-high viral load. My liver seemed to be in good shape with the various enzyme and function tests not indicating there was much damage. By this time my wife and I had read a great deal about Hep C (interestingly enough for those of you following the progression of side effects, I have forgotten a great deal of that information and have to keep looking stuff up to refresh my memory). We had lots of questions and Doctor C took a great deal of time answering them. Then he asked the fateful question. Do you want to be aggressive in your approach to the disease?

Yes, I replied. He told me that he knew of one of his colleagues currently enrolling a study for a Vertex compound VX-950 (now Telaprevir) and reached for the phone. He caught the doctor in, set up an appointment for two days hence and I was in the process of potentially beginning treatment for the disease. I spent the next 2 days doing research on VX-950. It is a protease inhibitor in phase 3 testing and has a Sustained Viral Response result of 62-64% in trials when it is combined with the Standard of Care (Interferon and Ribavirin). The study in question was an open label phase 3 study wherein every participant got the experimental drug; they were just testing for dosage effects. I admit I had a romantic fantasy about the possibility of being in the study: Man is diagnosed with Hep C on Halloween, goes into treatment in January, finishes treatment in December and is declared clear of the virus under 18 months after being diagnosed. We all have our fantasies, mine are usually not about drugs, but this time they were.

I went to the meeting, learned about the study, was told about the drug and the SOC side effects, signed the papers and went in for the lab tests the next day. It turned out that I showed a thyroid abnormality in my blood tests and there was not enough time to get me retested by the official lab in time to get me into the trial. So close and then the chance for the experimental drug was snatched away. It was particularly painful at the time because there are so few phase 3 tests of promising drugs and so very few tests as well wherein everyone gets the experimental drug and there is no placebo group.

As it turned out, it was probably for the best that I did not make the trial.

The next 3 months were spent in an extremely high-stress situation. My organization was moving an entire portion of its operation into a new space. I had been managing a great deal of the operation for my boss, who was in the middle of number of large projects. In January as the facilities move hit is most vital period, his wife became dangerously ill and they suffered a financial reverse which threatened to wipe out their life savings. I had to step forward and assume control of the entire project and manage it through the actual move and start-up of the new facility. I managed to do it, but the cost to my health was extreme. I was exhausted all the time. I went home from work every day and was capable of merely sitting for a few hours before going to bed. My wife is convinced to this day that the stress load spiked my viral load from the 4,000,000 range to the 6,500,000 number it hit in my next test in June.

If I had been going through treatment, I would never have been able to handle the job that was thrust upon me. I would most likely have collapsed either physically or mentally due to the strain. So, even though I lost the chance to get a late-stage experimental drug which raises SVR rates 40% above the standard of care treatment, my health may be better in the long run for missing the opportunity.

I did not examine all the ramifications of my decision before I made it. That is why it is so important to examine all sides of the issue before you reach a decision. It is hard to go through treatment. Even at its best, it is tiring and depressing and long. So think clearly and try to plan for as many eventualities as you can. It can make the difference between a successful outcome and something potentially very ugly.

Deciding About Treatment – Lot’s to Think About

I have had several people ask me why I decided to enter treatment. Specifically, they wanted to know why now?
My situation was this: 56 years old, high viral load at 13,000,000 per ml of blood, stage 1 liver disease, my Hep C had been symptomatic for 18-24 months.
Mine was not a desperate situation, no advanced liver disease, symptoms were present and annoying but not yet debilitating, and I was not in poor health generally. It came down to a long and serious consideration of a number of variables from health to work to family considerations. Here are some of the considerations:

What is the stage of your liver disease? Clearly, if you have advanced liver disease, treatment becomes something much more important and possibly mandatory than if your liver is not so deteriorated. If it early stage, you have the gift of time to consider all your options and potentially await additional treatment developments. If it is late stage, you have to decide much more quickly as the consequences of putting off treatment become exponentially more serious.

What is the state of your general health? Is the Hep C directly attacking your health through its symptoms and side effects and/or is the state of your liver creating additional health issues that are threatening or debilitating? To a certain extent the poorer your health, the more difficult the side effects of the treatment may be, but the more important it may well be to begin treatment in order to battle the effects of the disease. Again, the better your general health, the less immediate the decision becomes.

How are the general Hep C symptoms affecting you? Are you able to use available therapies to mitigate the effects of the symptoms of Hep C? Fatigue, Depression and Brain Fog are 3 of the more widely reported symptoms of Hep C. There are also joint pain, Ascites or fluid build-up in the abdomen, weight loss and the really serious symptoms of late-stage liver disease. There are a number of therapies for the general symptoms and if you are using them successfully and your life seems to be stable and at an acceptable level of health, this affects your decision. If the symptoms are beginning to overwhelm you, or become more than is tolerable for you, this also will have a large influence on your choice.

What is your health insurance situation? Hugely important of course. In countries with government financed health care systems this is a bit less of a concern, though the time before you can get authorization and enter treatment has to be considered carefully. If you have private health insurance, does it cover Hep C at all and if so, which of the therapies does it cover and for how long? If you eventually have to change insurers, will your Hep C be considered a per-existing condition and therefore the treatment would not be covered by insurance? Does this mean you should go for it while it is still covered? These are really tough questions and can definitely make the difference in treatment decisions. Something as basic as timing your treatment to begin the year right after your insurance renews can make all the difference in being covered through the entire length of treatment.

What is your employment or general work situation? This is a multifaceted question. If you are self-employed or run your own business, can you keep it going while not being able to put in the 40-60 hours per week that self-employment and business ownership generally require. Do you have people who can pick up the slack and help you during the 48 or more weeks that you will be, most likely, not at your best? Can your company survive if you have to take some time off without being able to work much at all?

If you are employed, what is your employer’s attitude going to be? Can you let anyone know you have Hep C? Is it clear to you that the attitudes at work would not be in your favor if they knew you had the disease? While it is illegal to discriminate against someone with a chronic disease like Hep C, remember that the burden of proof is on you. Should it come down to contesting a lay-off or firing, you have to bring the case and prove the action was because of Hep C.

If you believe that there is support from your employer what form will it take? Can you work a shortened workday or 4 day week? Can you take time off during the day to rest if necessary? Will they be supportive of the time you need to visit doctors and have tests? Do you have a sick leave policy or accumulated sick time that can be used to make up the time that you cannot be at the job? All these questions are vitally important and must be considered carefully before you make choices about treatment.


Which Genotype of the Virus am I and what are the chances for success? The common genotypes in North America are genotypes 1, 2 and 3. Genotype 1 is the most common and conversely, the most difficult to treat successfully. Genotypes 2 &3 are much less common in North America (and much more common in the rest of the world) and have a much higher success rate with treatment. The Standard of Care (SOC) is pegylated interferon (Pegasys, Peg-Intron) and Ribavirin (Copagus) taken for 48 weeks. The percentage of patients with a Sustained Virologic Response (SVR) is about 46% for genotype 1 and 80+% for genotypes 2 &3. So you have a bit less than a 50-50 shot to be cleared of the virus after treatment if you have the most common genotype present in the USA. The question boils down to: do you want to endure the effects of treatment for a year (and then some recovery time as well) for a 50-50 shot at a cure?

This is where the question of experimental drug studies comes into consideration. The study I am in uses a polymerase inhibitor (RO5024048) in addition to the SOC. The early studies indicated that it could result in a SVR rate of upwards of 70% in genotype 1 patients. There are very advanced compounds in the protease inhibitor family (Telaprevir is one example) that have shown in phase 3 studies that they have SVR rates of about 64%. When you see these sorts of results, the question changes quite a bit. Can I deal with treatment for a year if it means I have a 2-1 shot at clearing the virus or even a 3-1 shot?

What is your family situation? How stable is your relationship? How do you think your partner and/or children will react to the situation? Will they support you through the difficult parts of treatment? Does your family have the necessary financial means to deal with the potential loss of income and increased costs brought on by undergoing treatment? These are all highly personal questions whose answers are different for every individual considering treatment. They can also be questions whose answers change over time. Sometimes folks can start out very supportive and be worn down over time. Other times people step up to offer support and assistance in ways that can be astonishing in their generosity.

These are just some of the questions that arise when considering treatment. More to come…